FHL2 and neoplasm: FHL2 overexpression significantly enhanced tumor growth rates in both vehicle-treated and afatinib-treated nude mice xenografts (Figs. 6E & Fig. S2C), suggesting that FHL2 promotes resistance to afatinib and facilitates tumor progression.